31.82
7.13 (28.88%)
7.13 (28.88%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Iovance Biotherapeutics Inc | IOVA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 7.13 | 28.88% | 31.82 | 24.53 | 34.46 | 24.81 | 24.69 | 14:14:42 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 31.81 | 31.89 | 0.08 | 0.25% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 44,606 | 7,737,481 | $ 27.42 | $ 212,163,617 | 1,049,788 | 9.21 - 34.46 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:14:42 | 100 | $ 31.82 | USD |
Iovance Biotherapeutics Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 3.65B | 126.19M | $ -123.58M | -1.27 | - | 105.42M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Iovance Biotherapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IOVA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 23.82 | 34.46 | 23.585 | 25.01 | 1,254,172 | 8.00 | 33.59% |
| 1 Month | 21.72 | 34.46 | 20.93 | 23.77 | 866,513 | 10.10 | 46.5% |
| 3 Months | 22.43 | 34.46 | 20.93 | 25.41 | 1,184,745 | 9.39 | 41.86% |
| 6 Months | 19.87 | 34.46 | 17.67 | 22.76 | 1,205,089 | 11.95 | 60.14% |
| 1 Year | 10.01 | 34.46 | 9.21 | 19.63 | 1,375,412 | 21.81 | 217.88% |
| 3 Years | 7.20 | 34.46 | 4.45 | 15.24 | 1,014,257 | 24.62 | 341.94% |
| 5 Years | 8.57 | 34.46 | 4.24 | 13.83 | 765,488 | 23.25 | 271.3% |
Iovance Biotherapeutics Description
| Iovance Biotherapeutics Inc operates in the healthcare sector based in the United States. It is a pharmaceutical manufacturer attending to serious diseases such as cancer. The Company's lead pipeline candidate, LN-144, is an adoptive cell therapy using tumor-infiltrating lymphocytes (TIL) to treat patients with refractory metastatic melanoma. The TIL therapy involves growing a patient's special culture conditions outside the patient's body, or ex vivo, and then infusing the T cells back into the patient. |
